[1]
|
Joglar, J.A., Chung, M.K., Armbruster, A.L., et al. (2024) 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 149, e167. https://doi.org/10.1161/CIR.0000000000001207
|
[2]
|
Shi, S., Tang, Y., Zhao, Q., et al. (2022) Prevalence and Risk of Atrial Fibrillation in China: A National Cross-Sectional Epidemiological Study. The Lancet Regional Health—Western Pacific, 23, Article 100439. https://doi.org/10.1016/j.lanwpc.2022.100439
|
[3]
|
Du, X., Guo, L., Xia, S., et al. (2021) Atrial Fibrillation Prevalence, Awareness and Management in a Nationwide Survey of Adults in China. Heart, 107, 535-541. https://doi.org/10.1136/heartjnl-2020-317915
|
[4]
|
Sgreccia, D., Manicardi, M., Malavasi, V.L., et al. (2021) Comparing Outcomes in Asymptomatic and Symptomatic Atrial Fibrillation: A Systematic Review and Meta-Analysis of 81,462 Patients. Journal of Clinical Medicine, 10, Article 3979. https://doi.org/10.3390/jcm10173979
|
[5]
|
Boriani, G., Laroche, C., Diemberger, I., et al. (2015) Asymptomatic Atrial Fibrillation: Clinical Correlates, Management, and Outcomes in the EORP-AF Pilot General Registry. American Journal of Medicine, 128, 509-518. https://doi.org/10.1016/j.amjmed.2014.11.026
|
[6]
|
Schnabel, R.B., Sullivan, L.M., Levy, D., et al. (2009) Development of a Risk Score for Atrial Fibrillation (Framingham Heart Study): A Community-Based Cohort Study. The Lancet, 373, 739-745. https://doi.org/10.1016/S0140-6736(09)60443-8
|
[7]
|
Patton, K.K., Heckbert, S.R., Alonso, A., et al. (2013) N-Terminal Pro-B-Type Natriuretic Peptide as a Predictor of Incident Atrial Fibrillation in the Multi-Ethnic Study of Atherosclerosis: The Effects of Age, Sex and Ethnicity. Heart, 99, 1832-1836. https://doi.org/10.1136/heartjnl-2013-304724
|
[8]
|
朱晓庆, 陈韬, 沈娟, 等. 心房颤动预测: 从传统回归模型分析到人工智能模型[J]. 中国循环杂志, 2023, 38(12): 1305-1310.
|
[9]
|
Gage, B.F., Waterman, A.D., Shannon, W., et al. (2001) Validation of Clinical Classification Schemes for Predicting Stroke: Results from the National Registry of Atrial Fibrillation. JAMA, 285, 2864-2870. https://doi.org/10.1001/jama.285.22.2864
|
[10]
|
Atrial Fibrillation Investigators (1994) Risk Factors for Stroke and Efficacy of Antithrombotic Therapy in Atrial Fibrillation. Analysis of Pooled Data from Five Randomized Controlled Trials. Archives of Internal Medicine, 154, 1449-1457. https://doi.org/10.1001/archinte.154.13.1449
|
[11]
|
Hart, R.G., Pearce, L.A., McBride, R., et al. (1999) Factors Associated with Ischemic Stroke during Aspirin Therapy in Atrial Fibrillation: Analysis of 2012 Participants in the SPAF I-III Clinical Trials. Stroke, 30, 1223-1229. https://doi.org/10.1161/01.STR.30.6.1223
|
[12]
|
Lip, G.Y.H., Nieuwlaat, R., Pisters, R., et al. (2010) Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach: The Euro Heart Survey on Atrial Fibrillation. Chest, 137, 263-272. https://doi.org/10.1378/chest.09-1584
|
[13]
|
Chao, T.F., Lin, Y.J., Tsao, H.M., et al. (2011) CHADS2 and CHA2DS2-VASc Scores in the Prediction of Clinical Outcomes in Patients with Atrial Fibrillation after Catheter Ablation. Journal of the American College of Cardiology, 58, 2380-2385. https://doi.org/10.1016/j.jacc.2011.08.045
|
[14]
|
Teodorovich, N., Gandelman, G., Jonas, M., et al. (2023) The CHA2DS2-VASc Score Predicts Mortality in Patients Undergoing Coronary Angiography. Life, 13, Article 2026.
|
[15]
|
Lahad, K., Maor, E., Klempfner, R., et al. (2022) CHA2DS2-VASc Score Predicts the Risk of Stroke in Patients Hospitalized to the Internal Medicine Department without Known Atrial Fibrillation. Journal of General Internal Medicine, 37, 3355-3360. https://doi.org/10.1007/s11606-021-07262-x
|
[16]
|
Chao, T.F., Liu, C.J., Chen, S.J., et al. (2013) CHADS2 Score and Risk of New-Onset Atrial Fibrillation: A Nationwide Cohort Study in Taiwan. International Journal of Cardiology, 168, 1360-1363. https://doi.org/10.1016/j.ijcard.2012.12.011
|
[17]
|
Guo, Y., Tian, Y., Wang, H., et al. (2015) Prevalence, Incidence, and Lifetime Risk of Atrial Fibrillation in China: New Insights into the Global Burden of Atrial Fibrillation. Chest, 147, 109-119. https://doi.org/10.1378/chest.14-0321
|
[18]
|
Saliba, W., Gronich, N., Barnett-Griness, O. and Rennert, G. (2016) Usefulness of CHADS2 and CHA2DS2-VASc Scores in the Prediction of New-Onset Atrial Fibrillation: A Population-Based Study. The American Journal of Medicine, 129, 843-849. https://doi.org/10.1016/j.amjmed.2016.02.029
|
[19]
|
De Vos, C.B., Pisters, R., Nieuwlaat, R., et al. (2010) Progression from Paroxysmal to Persistent Atrial Fibrillation: Clinical Correlates and Prognosis. Journal of the American College of Cardiology, 55, 725-731. https://doi.org/10.1016/j.jacc.2009.11.040
|
[20]
|
Suenari, K., Chao, T.F., Liu, C.J., et al. (2017) Usefulness of HATCH Score in the Prediction of New-Onset Atrial Fibrillation for Asians. Medicine, 96, e5597. https://doi.org/10.1097/MD.0000000000005597
|
[21]
|
Hsieh, C.Y., Lee, C.H., Wu, D.P., et al. (2018) Prediction of New-Onset Atrial Fibrillation after First-Ever Ischemic Stroke: A Comparison of CHADS2, CHA2DS2-VASc and HATCH Scores and the Added Value of Stroke Severity. Atherosclerosis, 272, 73-79. https://doi.org/10.1016/j.atherosclerosis.2018.03.024
|
[22]
|
Hu, W.S. and Lin, C.L. (2017) Comparison of CHA2DS2-VASc, CHADS2 and HATCH Scores for the Prediction of New-Onset Atrial Fibrillation in Cancer Patients: A Nationwide Cohort Study of 760,339 Study Participants with Competing Risk Analysis. Atherosclerosis, 266, 205-211. https://doi.org/10.1016/j.atherosclerosis.2017.10.007
|
[23]
|
Li, Y.G., Pastori, D., Farcomeni, A., et al. (2019) A Simple Clinical Risk Score (C2HEST) for Predicting Incident Atrial Fibrillation in Asian Subjects: Derivation in 471,446 Chinese Subjects, with Internal Validation and External Application in 451,199 Korean Subjects. Chest, 155, 510-518. https://doi.org/10.1016/j.chest.2018.09.011
|
[24]
|
Hu, W.S. and Lin, C.L. (2020) Prediction of New-Onset Atrial Fibrillation for General Population in Asia: A Comparison of C2HEST and HATCH Scores. International Journal of Cardiology, 313, 60-63. https://doi.org/10.1016/j.ijcard.2020.03.036
|
[25]
|
Li, Y.G., Bisson, A., Bodin, A., et al. (2019) C2 HEST Score and Prediction of Incident Atrial Fibrillation in Poststroke Patients: A French Nationwide Study. Journal of the American Heart Association, 8, e012546. https://doi.org/10.1161/JAHA.119.012546
|
[26]
|
Bekiaridou, A., Kartas, A., Moysidis, D.V., et al. (2022) The Bidirectional Relationship of Thyroid Disease and Atrial Fibrillation: Established Knowledge and Future Considerations. Reviews in Endocrine and Metabolic Disorders, 23, 621-630. https://doi.org/10.1007/s11154-022-09713-0
|
[27]
|
Aronson, D., Shalev, V., Katz, R., et al. (2018) Risk Score for Prediction of 10-Year Atrial Fibrillation: A Community-Based Study. Thrombosis and Haemostasis, 118, 1556-1563. https://doi.org/10.1055/s-0038-1668522
|
[28]
|
Schnabel, R.B., Aspelund, T., Li, G., et al. (2010) Validation of an Atrial Fibrillation Risk Algorithm in Whites and African Americans. Archives of Internal Medicine, 170, 1909-1917. https://doi.org/10.1001/archinternmed.2010.434
|
[29]
|
Chamberlain, A.M., Agarwal, S.K., Folsom, A.R., et al. (2011) A Clinical Risk Score for Atrial Fibrillation in a Biracial Prospective Cohort (From the Atherosclerosis Risk in Communities [ARIC] Study). The American Journal of Cardiology, 107, 85-91. https://doi.org/10.1016/j.amjcard.2010.08.049
|
[30]
|
Alonso, A., Krijthe, B.P., Aspelund, T., et al. (2013) Simple Risk Model Predicts Incidence of Atrial Fibrillation in a Racially and Geographically Diverse Population: The CHARGE-AF Consortium. Journal of the American Heart Association, 2, e000102. https://doi.org/10.1161/JAHA.112.000102
|
[31]
|
Brunner, K.J., Bunch, T.J., Mullin, C.M., et al. (2014) Clinical Predictors of Risk for Atrial Fibrillation: Implications for Diagnosis and Monitoring. Mayo Clinic Proceedings, 89, 1498-1505. https://doi.org/10.1016/j.mayocp.2014.08.016
|
[32]
|
Segan, L., Canovas, R., Nanayakkara, S., et al. (2023) New-Onset Atrial Fibrillation Prediction: The HARMS2-AF Risk Score. European Heart Journal, 44, 3443-3452. https://doi.org/10.1093/eurheartj/ehad375
|
[33]
|
Chao, T.F., Chiang, C.E., Chen, T.J., et al. (2021) Clinical Risk Score for the Prediction of Incident Atrial Fibrillation: Derivation in 7 220 654 Taiwan Patients with 438 930 Incident Atrial Fibrillations during a 16-Year Follow-Up. Journal of the American Heart Association, 10, e020194. https://doi.org/10.1161/JAHA.120.020194
|
[34]
|
Kokubo, Y., Watanabe, M., Higashiyama, A., et al. (2017) Development of a Basic Risk Score for Incident Atrial Fibrillation in a Japanese General Population―The Suita Study. Circulation Journal, 81, 1580-1588. https://doi.org/10.1253/circj.CJ-17-0277
|
[35]
|
Suissa, L., Bertora, D., Lachaud, S., et al. (2009) Score for the Targeting of Atrial Fibrillation (STAF) a New Approach to the Detection of Atrial Fibrillation in the Secondary Prevention of Ischemic Stroke. Stroke, 40, 2866-2868. https://doi.org/10.1161/STROKEAHA.109.552679
|
[36]
|
Verdecchia, P., Angeli, F. and Reboldi, G. (2018) Hypertension and Atrial Fibrillation: Doubts and Certainties from Basic and Clinical Studies. Circulation Research, 122, 352-368. https://doi.org/10.1161/CIRCRESAHA.117.311402
|
[37]
|
Wong, C.X., Sullivan, T., Sun, M.T., et al. (2015) Obesity and the Risk of Incident, Post-Operative, and Post-Ablation Atrial Fibrillation: A Meta-Analysis of 626,603 Individuals in 51 Studies. JACC: Clinical Electrophysiology, 1, 139-152. https://doi.org/10.1016/j.jacep.2015.04.004
|
[38]
|
Cha, Y.M., Redfield, M.M., Shen, W.K., et al. (2004) Atrial Fibrillation and Ventricular Dysfunction: A Vicious Electromechanical Cycle. Circulation, 109, 2839-2843. https://doi.org/10.1161/01.CIR.0000132470.78896.A8
|